Plain-English translation of NCT07325136 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called to see if it can help people with small cell lung cancer that has returned or stopped responding to chemotherapy. Researchers will study how safe the medication is and how well it works, both when taken alone and when combined with another treatment called . The goal is to find the right dose and understand whether this new approach can help patients like you.
Small cell lung cancer often comes back or stops responding to standard chemotherapy, leaving patients with limited options. This trial is testing whether this new medication could offer hope to people in that situation by targeting their cancer in a different way.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic regularly to receive the medication and have blood tests and scans to monitor how you're responding and check for side effects. Depending on which group you're assigned to, you may receive the medication alone or combined with another treatment. The study has different phases—some participants help find the safest dose, while others receive doses that have already been tested to see how well the treatment works.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
United States